Forecast: Import of Pharmaceutical Products to Sweden

The import of pharmaceutical products to Sweden has witnessed a general upward trend over the years, albeit with some fluctuations. In 2023, the import value stood at approximately $4.96 billion USD. Reviewing the data, there were notable variations year-on-year, with significant declines in 2015 and 2022. However, the market has rebounded, showing steady growth thereafter.

Over the last two years, the year-on-year variation has been -7.46% in 2022 and 1.72% in 2023. Meanwhile, the compound annual growth rate (CAGR) over the last five years (2019 to 2023) has been modest at 1.56%. Looking ahead, forecasts up to 2028 predict a 1.16% CAGR, equating to a 5.91% growth rate over this period.

**Future Trends to Watch For:**

• Increased investment in pharmaceutical R&D which might boost import volumes.
• Potential market impacts due to healthcare policy changes within the EU.
• Technological advancements in pharmaceuticals driving import of novel medications.
• Shifts in global trade agreements that could influence import dynamics.